$12.58
3.11% today
NYSE, May 02, 07:46 pm CET
ISIN
US1638511089
Symbol
CC

Chemours Co. Target price 2025 - Analyst rating & recommendation

Chemours Co. Classifications & Recommendation:

Buy
58%
Hold
33%
Sell
8%

Chemours Co. Price Target

Target Price $19.60
Price $12.20
Potential
Number of Estimates 10
10 Analysts have issued a price target Chemours Co. 2026 . The average Chemours Co. target price is $19.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 7 Analysts recommend Chemours Co. to buy, 4 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chemours Co. stock has an average upside potential 2026 of . Most analysts recommend the Chemours Co. stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 5.78 5.85
4.87% 1.19%
EBITDA Margin 13.13% 15.05%
262.66% 14.65%
Net Margin 1.47% 4.08%
137.45% 176.97%

8 Analysts have issued a sales forecast Chemours Co. 2025 . The average Chemours Co. sales estimate is

$5.9b
Unlock
. This is
1.17% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.0b 3.48%
Unlock
, the lowest is
$5.6b 3.19%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.8b 4.87%
2025
$5.9b 1.19%
Unlock
2026
$6.1b 4.20%
Unlock
2027
$6.4b 5.42%
Unlock

8 Analysts have issued an Chemours Co. EBITDA forecast 2025. The average Chemours Co. EBITDA estimate is

$880m
Unlock
. This is
15.85% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$910m 19.78%
Unlock
, the lowest is
$825m 8.55%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $759m 245.00%
2025
$880m 16.01%
Unlock
2026
$1.0b 14.19%
Unlock
2027
$1.1b 9.86%
Unlock

EBITDA Margin

2024 13.13% 262.66%
2025
15.05% 14.65%
Unlock
2026
16.49% 9.57%
Unlock
2027
17.19% 4.24%
Unlock

3 Chemours Co. Analysts have issued a net profit forecast 2025. The average Chemours Co. net profit estimate is

$239m
Unlock
. This is
175.70% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$266m 206.90%
Unlock
, the lowest is
$219m 152.53%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $85.2m 135.63%
2025
$239m 180.54%
Unlock
2026
$351m 46.78%
Unlock
2027
$393m 12.17%
Unlock

Net Margin

2024 1.47% 137.45%
2025
4.08% 176.97%
Unlock
2026
5.75% 40.93%
Unlock
2027
6.12% 6.43%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.57 1.60
135.63% 180.70%
P/E 7.63
EV/Sales 0.93

3 Analysts have issued a Chemours Co. forecast for earnings per share. The average Chemours Co. EPS is

$1.60
Unlock
. This is
175.86% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$1.78 206.90%
Unlock
, the lowest is
$1.46 151.72%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.57 135.63%
2025
$1.60 180.70%
Unlock
2026
$2.35 46.88%
Unlock
2027
$2.63 11.91%
Unlock

P/E ratio

Current 21.07 223.72%
2025
7.63 63.79%
Unlock
2026
5.20 31.85%
Unlock
2027
4.63 10.96%
Unlock

Based on analysts' sales estimates for 2025, the Chemours Co. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.95 12.84%
2025
0.93 1.65%
Unlock
2026
0.90 4.04%
Unlock
2027
0.85 5.13%
Unlock

P/S ratio

Current 0.32 53.25%
2025
0.31 1.17%
Unlock
2026
0.30 4.01%
Unlock
2027
0.28 5.15%
Unlock

Current Chemours Co. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Truist Securities
Locked
Locked
Locked Apr 14 2025
Barclays
Locked
Locked
Locked Apr 01 2025
Mizuho
Locked
Locked
Locked Mar 27 2025
Barclays
Locked
Locked
Locked Feb 24 2025
BMO Capital
Locked
Locked
Locked Feb 19 2025
Truist Securities
Locked
Locked
Locked Jan 28 2025
Morgan Stanley
Locked
Locked
Locked Jan 13 2025
Analyst Rating Date
Locked
Truist Securities:
Locked
Locked
Apr 14 2025
Locked
Barclays:
Locked
Locked
Apr 01 2025
Locked
Mizuho:
Locked
Locked
Mar 27 2025
Locked
Barclays:
Locked
Locked
Feb 24 2025
Locked
BMO Capital:
Locked
Locked
Feb 19 2025
Locked
Truist Securities:
Locked
Locked
Jan 28 2025
Locked
Morgan Stanley:
Locked
Locked
Jan 13 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today